NCT00359723View on ClinicalTrials.gov

Methylphenidate and Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

March 31, 2006

Conditions
Parkinson's Disease
Interventions
DRUG

methylphenidate

Trial Locations (1)

97239

Department of Neurology, OP-2, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Oregon Health and Science University

OTHER

NCT00359723 - Methylphenidate and Parkinson's Disease | Biotech Hunter | Biotech Hunter